Skip to main content
SpringerLink
Log in

Genetic Risk Factors in Venous Thromboembolism

  • Chapter
  • First Online:
Thrombosis and Embolism: from Research to Clinical Practice

Part of the book series: Advances in Experimental Medicine and Biology ((AIM,volume 906))

Abstract

Genetic risk factors predispose to thrombophilia and play the most important etiopathogenic role in venous thromboembolism (VTE) in people younger than 50 years old. At least one inherited risk factor could be found in about half of the cases with a first episode of idiopathic VTE.

Roughly, genetic risk factors are classified into two main categories: loss of function mutations (such as deficiencies of antithrombin, protein C, protein S) and gain of function mutations, (such as prothrombin mutation G20210A, factor V Leiden). A revolutionary contribution to the genetic background of VTE was brought by the achievements of the genome-wide association studies which analyze the association of a huge number of polymorphisms in large sample size.

Hereditary thrombophilia testing should be done only in selected cases. The detection of hereditary thrombophilia has impact on the management of the anticoagulation in children with purpura fulminans, pregnant women at risk of VTE and may be useful in the assessment of the risk for recurrent thrombosis in patients presenting an episode of VTE at a young age (<40 years) and in cases with positive family history regarding thrombosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kreidy R (2014) Influence of acquired and genetic risk factors on the prevention, management, and treatment of thromboembolic disease. Int J Vasc Med. http://dx.doi.org/10.1155/2014/859726

  2. Cushman M (2005) Inherited risk factors for venous thrombosis. Hematology 1:452–457

    Article  Google Scholar 

  3. Prandoni P (2005) Acquired risk factors for venous thromboembolism in medical patients. Hematol Am Soc Hematol Educ Program 2005(1):458–461

    Google Scholar 

  4. Coppens M, Reijnders JH, Middeldorp S, Doggen CJ, Rosendaal FR (2008) Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis. J Thromb Haemost 6(9):1474–7

    Article  CAS  PubMed  Google Scholar 

  5. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S et al (2010) Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 149:209–220

    Article  PubMed  Google Scholar 

  6. Reitsma PH, Rosendaal FR (2007) Past and future of genetic research in thrombosis. J Thromb Haemost 5(S1):264–269

    Article  CAS  PubMed  Google Scholar 

  7. Patnaik MM, Moll S (2008) Inherited antithrombin deficiency: a review. Haemophilia 14:1229–1239

    Article  CAS  PubMed  Google Scholar 

  8. Kujovich JL, Factor V (2011) Leiden thrombophilia. Genet Med 13:1–16

    Article  CAS  PubMed  Google Scholar 

  9. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88(10):3698–3703

    CAS  PubMed  Google Scholar 

  10. Soria JM, Morange PE, Vila J, Souto JC, Moyano M, Trégouët DA et al (2014) Multilocus genetic risk scores for venous thromboembolism risk assessment. J Am Heart Assoc 3(5):e001060. doi:10.1161/JAHA.114.001060

    Article  PubMed  PubMed Central  Google Scholar 

  11. Dordevic V, Pruner I, Radojkovic D (2014) Molecular basis of thrombophilia. J Med Biochem 33:22–27

    Google Scholar 

  12. Hickey SE, Curry CJ, Toriello HV (2013) ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genet Med 15(2):153–156

    Article  CAS  PubMed  Google Scholar 

  13. Tang W, Teichert M, Chasman DI, Heit JA, Morange PE, Li G et al (2013) A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Genet Epidemiol 37(5):512–21. doi:10.1002/gepi.21731

    Article  PubMed  PubMed Central  Google Scholar 

  14. Martinelli I, De Stefano V, Mannucci PM (2014) Inherited risk factors for venous thromboembolism. Nat Rev Cardiol 11:140–156

    Article  CAS  PubMed  Google Scholar 

  15. Rosendaal FR (1999) Venous thrombosis – a multicausal disease. Lancet 353:1167–1173

    Article  CAS  PubMed  Google Scholar 

  16. Bertina RM1, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369(6475):64–67

    Google Scholar 

  17. Jadaon M (2011) Epidemiology of activated protein C resistance and factor V Leiden mutation in the Mediterranean region. Mediterr J Hematol Infect Dis 3(1):e2011037

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lucotte G, Mercier G (2001) Population genetics of factor V Leiden in Europe. Blood Cells Mol Dis 27:362–367

    Article  CAS  PubMed  Google Scholar 

  19. Hotoleanu C, Popp R, Trifa A (2014) Factor V Leiden, prothrombin G20210A and MTHFR C677T mutations in Romanian patients with deep venous thrombosis. HVM Bioflux 6(1):15–19

    CAS  Google Scholar 

  20. Renner W, Koppel H, Hoffmann C, Schallmoser K, Stanger O, Toplak H et al (2000) Prothrombin G20210A, Factor V Leiden, and Factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria. Thromb Res 99:35–39

    Article  CAS  PubMed  Google Scholar 

  21. Nizankowska-Mogilnicka E, Adamek L, Grzanka P, Domagala TB, Sanak M, Krzanowski M et al (2003) Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur Respir J 21:25–30

    Article  CAS  PubMed  Google Scholar 

  22. Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Old and new risk factors for upper extremity deep venous thrombosis. J Thromb Haemost 3(11):2471–8

    Article  CAS  PubMed  Google Scholar 

  23. van Langevelde K, Lijfering WM, Rosendaal FR, Cannegieter SC (2011) Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study. Blood 118(15):4239–4241

    Article  PubMed  Google Scholar 

  24. van Langevelde K, Flinterman LE, van Hylckama VA, Rosendaal FR, Cannegieter SC (2012) Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. Blood 120(5):933–46

    Article  PubMed  Google Scholar 

  25. Castoldi E, Rosing J (2010) APC resistance: biological basis and acquired influences. J Thromb Haemost 8(3):445–453

    Article  CAS  PubMed  Google Scholar 

  26. van Stralen CJ, Doggen CJM, Bezemer ID, Pomp ER, Lisman T, Rosendaal FR (2008) Mechanisms of the factor V Leiden paradox. Arterioscler Thromb Vasc Biol 28:1872–1877

    Article  PubMed  Google Scholar 

  27. Kim RJ, Becker RC (2003) Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 146(6):948–57

    Article  CAS  PubMed  Google Scholar 

  28. Page C, Rubin LE, Gusberg RJ, Dardik A (2005) Arterial thrombosis associated with heterozygous factor V Leiden disorder, hyperhomocysteinemia, and peripheral arterial disease: importance of synergistic factors. J Vasc Surg 42:1014–1018

    Article  PubMed  Google Scholar 

  29. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293:2352–2361

    Article  CAS  PubMed  Google Scholar 

  30. Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW (2006) Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med 166:729–736

    Article  CAS  PubMed  Google Scholar 

  31. Lijfering WM, Middeldorp S, Veeger NJ, Hamulyak K, Prins MH, Bulleret HR et al (2010) Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of Factor V Leiden and prothrombin G20210A. Circulation 121:1706–1712

    Article  CAS  PubMed  Google Scholar 

  32. Pabinger I, Ay C, Dunkler D, Thaler J, Reitter EM, Maros C et al (2015) Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients – results from the Vienna Cancer And Thrombosis Study (CATS). J Thromb Haemost 13:17–22

    Article  CAS  PubMed  Google Scholar 

  33. Gerhardt A, Scharf RE, Beckmann MW et al (2000) Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 342:374–380

    Article  CAS  PubMed  Google Scholar 

  34. Lensen RP, Bertina RM, de Ronde H, Vandenbroucke JP, Rosendaal FR (2000) Venous thrombotic risk in family members of unselected individuals with Factor V Leiden. Thromb Haemost 83:817–821

    CAS  PubMed  Google Scholar 

  35. Emmerich J, Rosendaal FR, Cattaneo M et al (2001) Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism—pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study group for pooled-analysis in venous thromboembolism. Thromb Haemost 86:809–816

    CAS  PubMed  Google Scholar 

  36. Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ (1997) Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 95(7):1777–82

    Article  CAS  PubMed  Google Scholar 

  37. Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA, ACMG Factor V Leiden Working Group (2001) Leiden Working Group. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 3(2):139–148

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Practical-Haemostasis.com (2015) A practical guide to laboratory haemostasis. http://practical-haemostasis.com/Thrombophilia%20Tests/apcr_assays.html. Downloaded 10 Feb 2015.

  39. Spector EB, Grody WW, Matteson CJ, Palomaki GE, Bellissimo DB, Wolf DJ et al (2005) Technical standards and guidelines: venous thromboembolism (factor V Leiden and prothrombin 20210G>A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories. Genet Med 7:444–453

    Article  PubMed  Google Scholar 

  40. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group (2011) Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. Genet Med 13(1):67–76

    Google Scholar 

  41. Jadaon MM (2011) Epidemiology of prothrombin G20210A mutation in the Mediterranean region. Mediterr J Hematol Infect Dis 3(1):e2011054. doi:10.4084/MJHID.2011.054

    Article  PubMed  PubMed Central  Google Scholar 

  42. Miyawaki Y, Suzuki A, Fujita J, Maki A, Okuyama E, Murata M et al (2012) Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med 366(25):2390–6

    Article  CAS  PubMed  Google Scholar 

  43. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS et al (1998) Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 79(4):706–8

    CAS  PubMed  Google Scholar 

  44. Aznar J, Vaya A, Estelles A, Mira Y, Segui R, Villa P et al (2000) Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Haematologica 85(12):1271–1276

    CAS  PubMed  Google Scholar 

  45. Young G, Manco-Johnson M, Gill JC, Dimichele DM, Tarantino MD, Abshire T et al (2003) Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study. J Thromb Haemost 1(5):958–62

    Article  CAS  PubMed  Google Scholar 

  46. Bank I, Libourel EJ, Middeldorp S, van Pampus ECM, Koopman MMW, Hamulyák K et al (2004) Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but Not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med 164(17):1932–1937

    Article  CAS  PubMed  Google Scholar 

  47. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Rossi E, Chiusolo P et al (2001) The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation. Br J Haematol 113(3):630–5

    Article  PubMed  Google Scholar 

  48. Silver RM, ZhaoY, Spong CY, Sibai B, Wendel G, Wenstrom K et al (2010) Prothrombin Gene G20210A Mutation and Obstetric Complications. Obst Gynecol 115(1):14–20

    Google Scholar 

  49. Warren JE, Simonsen SE, Branch DW, Porter TF, Silver RM (2009) Thromboprophylaxis and pregnancy outcomes in asymptomatic women with inherited thrombophilias. Am J Obstet Gynecol 200(3):281.e1–5

    Google Scholar 

  50. Dahlback B (2008) Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 112(1):19–27

    Article  PubMed  Google Scholar 

  51. Goldenberg NA, Manco-Johnson MJ (2008) Protein C deficiency. Haemophilia 14:1214–1221

    Article  CAS  PubMed  Google Scholar 

  52. Marlar RA, Mastovich S (1990) Hereditary protein C deficiency: a review of the genetics, clinical presentation, diagnosis and treatment. Blood Coagul Fibrinolysis 1:319–330

    Article  CAS  PubMed  Google Scholar 

  53. Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J (1997) Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism – results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost 77(3):444–51

    CAS  PubMed  Google Scholar 

  54. Sommeijer DW, Reitsma PH (2015) Genetic risk factors for disseminated intravascular coagulation. Madame Curie Bioscience Database [Internet]. http://www.ncbi.nlm.nih.gov/books/NBK6069/. Downloaded in 19 Feb 2015

  55. Brummel-Ziedins KE, Orfeo T, Callas PW, Gissel M, Mann KG, Bovill EG (2012) The prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation. Miyata T (ed). PLoS ONE 7(9):e44378. doi:10.1371/journal.pone.0044378

    Google Scholar 

  56. Khor B, van Cot E (2010) Laboratory tests for protein C deficiency. Am J Hematol 85:440–442

    Article  PubMed  Google Scholar 

  57. Maqbool S, Rastogi V, Seth A, Singh S, Kumar V, Mustaqueem A (2013) Protein-C deficiency presenting as pulmonary embolism and myocardial infarction in the same patient. Thromb J: 11–19. doi:10.1186/1477-9560-11-19

    Google Scholar 

  58. Sugiura M (2005) Pregnancy and delivery in protein C-deficiency. Curr Drug Targets 6(5):577–83

    Article  CAS  PubMed  Google Scholar 

  59. Michiels JJ, Hamulyak K (1998) Laboratory diagnosis of hereditary thrombophilia. Semin Thromb Hemost 24(4):309–20

    Article  CAS  PubMed  Google Scholar 

  60. Minuk L, Lazo-Langner A, Kovacs J, Robbins M, Morrow B, Kovacs M (2010) Normal levels of protein C and protein S tested in the acute phase of a venous thromboembolic event are not falsely elevated. Thrombosis J 8:10. doi:10.1186/1477-9560-8-10

    Article  Google Scholar 

  61. Pescatore SL (2001) Clinical management of protein C deficiency. Expert Opin Pharmacother 2(3):431–9

    Article  CAS  PubMed  Google Scholar 

  62. Kate MKT, van der Meer J (2008) Protein S deficiency: a clinical perspective. Haemophilia 14:1222–1228

    PubMed  Google Scholar 

  63. Yin T, Miyata T (2009) Venous thromboembolic risk and protein S deficiency: ethnic difference and remaining issues. J Geriatr Cardiol 6:11–19

    CAS  Google Scholar 

  64. Pintao MC, Ribeiro DD, Bezemer ID, Garcia AA, de Visser MCH, Doggen CJM et al (2013) Protein S levels and the risk of venous thrombosis: results from the MEGA case-control study. Blood 122(18):3210–3219

    Google Scholar 

  65. Van Vlijmen EF, Brouwer JL, Veeger NJ, Eskes TK, de Graeff PA, van der Meer J (2007) Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study. Arch Intern Med 167:282–9

    Article  PubMed  Google Scholar 

  66. Marlar RA, Gausman JN (2011) Protein S abnormalities: a diagnostic nightmare. Am J Hematol 86(5):418–21

    Article  CAS  PubMed  Google Scholar 

  67. Kemkes-Matthes B (1992) Acquired protein S deficiency. Clin Investig 70:529–534

    Article  CAS  PubMed  Google Scholar 

  68. Fair DS, Revak DJ (1984) Quantitation of human protein S in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Thromb Res 36(6):527

    Article  CAS  PubMed  Google Scholar 

  69. Cosmi B, Palareti G (2004) Extended treatment for venous thromboembolism: how long is long enough? Curr Hematol Rep 3(5):375–81

    PubMed  Google Scholar 

  70. Martinelli I, Bucciarelli P, Artoni A, Fossali EF, Passamonti SM, Tripodi A et al (2013) Anticoagulant treatment with rivaroxaban in severe protein S deficiency. Pediatrics 132(5):e1435–9. doi:10.1542/peds.2013-1156

    Article  PubMed  Google Scholar 

  71. Zhou A, Huntington JA, Carrell RW (1999) Formation of the antithrombin heterodimer in vivo and the onset of thrombosis. Blood 94(10):3388–96

    CAS  PubMed  Google Scholar 

  72. Perry DJ (1994) Antithrombin and its inherited deficiencies. Blood Rev 8:37

    Article  CAS  PubMed  Google Scholar 

  73. Patnaik MM, Moll S (2008) Inherited antithrombin deficiency: a review. Haemophilia 14(6):1229–39

    Article  CAS  PubMed  Google Scholar 

  74. Fischer R, Sachs UJ, Heidinger KS, Eisenburger D, Kemkes-Matthes B (2013) Prevalence of hereditary antithrombin mutations is higher than estimated in patients with thrombotic events. Blood Coagul Fibrinolysis 24(4):444–8

    Article  CAS  PubMed  Google Scholar 

  75. Rodgers GM (2009) Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update Thromb Haemost 101(5):806–12

    CAS  PubMed  Google Scholar 

  76. Vicente V, Rodriguez C, Soto I, Fernandez M, Moraleda JM (1994) Risk of thrombosis during pregnancy and post-partum in hereditary thrombophilia. Am J Hematol 46(2):151–2

    Article  CAS  PubMed  Google Scholar 

  77. Sabadell J, Casellas M, Alijotas-Reig J, Arellano-Rodrigo E, Cabero L (2010) Inherited antithrombin deficiency and pregnancy: maternal and fetal outcomes. Eur J Obstet Gynecol Reprod Biol 149(1):47–51

    Article  CAS  PubMed  Google Scholar 

  78. Hotoleanu C, Trifa A, Popp R, Fodor D (2013) The importance of homozygous polymorphisms of methylenetetrahydrofolate reductase gene in Romanian patients with idiopathic venous thromboembolism. Balkan Med J 30:197–203

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Fay WP (2012) Homocysteine and thrombosis: guilt by association? Blood 119(13):2977–2978

    Article  CAS  PubMed  Google Scholar 

  80. Yafei W, Lijun P, Jinfeng W, Xiaoying Z (2012) Is the prevalence of MTHFR C677T polymorphism associated with ultraviolet radiation in Eurasia? J Hum Genet 57(12):1–7

    Google Scholar 

  81. Hickey SE, Curry CJ, Toriello HV (2013) ACMG practice guideline: lack of evidence for MTHFR polymorphism testing. Genet Med 15:153–156

    Article  CAS  PubMed  Google Scholar 

  82. Castro-Marrero J, Balada E, Ordi-Ros J, Vilardell-Tarres M (2015) Genetics of antiphospholipid syndrome. www.intechopen.com. Downloaded 17 Mar 2015

  83. von Scheven E, Elder ME (2005) Association between beta2-glycoprotein I gene polymorphisms and pediatric SLE and antiphospholipid antibodies. Lupus 14(6):440–4

    Article  Google Scholar 

  84. Ishikura K, Wada H, Kamikura Y, Hattori K, Fukuzawa T, Yamada N et al (2004) High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Am J Hematol 76(4):338–42

    Article  CAS  PubMed  Google Scholar 

  85. Meroni PL, Chighizola CB, Rovelli F, Gerosa M (2014) Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers. Arthritis Res Ther 16:209

    Article  PubMed  PubMed Central  Google Scholar 

  86. Neville C, Rauch J, Kassis J, Chang ER, Joseph L, Le Comte M, Fortin PR (2003) Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Thromb Haemost 90(1):108

    CAS  PubMed  PubMed Central  Google Scholar 

  87. Giannakopoulos B, Passam F, Ioannou Y, Krilis SA (2009) How we diagnose the antiphospholipid syndrome. Blood 113(5):985

    Article  CAS  PubMed  Google Scholar 

  88. Keeling D, Mackie I, Moore GW, Greer IA (2012) Greaves M and British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 157:47–58

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department 5, Iuliu Hatieganu University of Medicine and Pharmacy, 8, Victor Babes street, 400012, Cluj-Napoca, Romania

    Cristina Hotoleanu M.D., Ph.D.

Authors
  1. Cristina Hotoleanu M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cristina Hotoleanu M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden

    Md. Shahidul Islam

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Hotoleanu, C. (2016). Genetic Risk Factors in Venous Thromboembolism. In: Islam, M. (eds) Thrombosis and Embolism: from Research to Clinical Practice. Advances in Experimental Medicine and Biology(), vol 906. Springer, Cham. https://doi.org/10.1007/5584_2016_120

Download citation

  • DOI: https://doi.org/10.1007/5584_2016_120

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-22107-6

  • Online ISBN: 978-3-319-22108-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation